The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

被引：145
作者：
Gifford, Robert J. [1 ]
Liu, Tommy F. [1 ]
Rhee, Soo-Yon [1 ]
Kiuchi, Mark [1 ]
Hue, Stephane [2 ]
Pillay, Deenan [2 ,3 ]
Shafer, Robert W. [1 ]
机构：
[1] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
[2] UCL, Dept Infect, London WC1E 6BT, England
[3] Hlth Protect Agcy, Ctr Infect, Colindale, England
来源：
BIOINFORMATICS | 2009年 / 25卷 / 09期
关键词：
REVERSE-TRANSCRIPTASE; EPIDEMIOLOGIC SURVEILLANCE; ANTIRETROVIRAL TREATMENT; SEQUENCE; TRANSMISSION; MUTATIONS; PROTEASE; EUROPE;
D O I：
10.1093/bioinformatics/btp134
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
The calibrated population resistance (CPR) tool is a web-accessible program for performing standardized genotypic estimation of transmitted HIV-1 drug resistance. The program is linked to the Stanford HIV drug resistance database and can additionally perform viral genotyping and algorithmic estimation of resistance to specific antiretroviral drugs.
引用
收藏
页码：1197 / 1198
页数：2
相关论文
共 19 条
  • [1] Bennett DE, 2008, ANTIVIR THER, V13, P25
  • [2] Bennett DE, 2008, ANTIVIR THER, V13, P1
  • [3] Bertagnolio S, 2007, ANTIVIR THER, V12, P107
  • [4] Burns S, 2007, AIDS, V21, P1035, DOI 10.1097/QAD.0b013e3280b07761
  • [5] Sequence editing by Apolipoprotein B RNA-editing catalytic component-B and epidemiological surveillance of transmitted HIV-1 drug resistance
    Gifford, Robert J.
    Rhee, Soo-Yon
    Eriksson, Nicolas
    Liu, Tommy F.
    Kiuchi, Mark
    Das, Amar K.
    Shafer, Robert W.
    [J]. AIDS, 2008, 22 (06) : 717 - 725
  • [6] The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
    Gilks, Charles F.
    Crowley, Siobhan
    Ekpini, Rene
    Gove, Sandy
    Perriens, Jos
    Souteyrand, Yves
    Sutherland, Don
    Vitoria, Marco
    Guerma, Teguest
    De Cock, Kevin
    [J]. LANCET, 2006, 368 (9534) : 505 - 510
  • [7] APOBEC-mediated viral restriction: not simply editing?
    Holmes, Rebecca K.
    Malim, Michael H.
    Bishop, Kate N.
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2007, 32 (03) : 118 - 128
  • [8] Huang XQ, 1996, COMPUT APPL BIOSCI, V12, P497
  • [9] Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects
    Kuritzkes, Daniel R.
    Lalama, Christina M.
    Ribaudo, Heather J.
    Marcial, Michelle
    Meyer, William A., III
    Shikuma, Cecilia
    Johnson, Victoria A.
    Fiscus, Susan A.
    D'Aquila, Richard T.
    Schackman, Bruce R.
    Acosta, Edward P.
    Gulick, Roy M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (06) : 867 - 870
  • [10] Antiretroviral-drug resistance among patients recently infected with HIV
    Little, SJ
    Holte, S
    Routy, JP
    Daar, ES
    Markowitz, M
    Collier, AC
    Koup, RA
    Mellors, JW
    Connick, E
    Conway, B
    Kilby, M
    Wang, L
    Whitcomb, JM
    Hellmann, NS
    Richman, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) : 385 - 394
12